A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
An open-label, multicenter study of ZL-1310 as a single agent and in combination with Atezolizumab (with and without Carboplatin) to evaluate the safety, efficacy, and pharmacokinetics in subjects with small cell lung cancer
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowotwór płuca rozprzestzeniony na inne części ciała lub zaawansowany
- •Wiek co najmniej 18 lat
- •Ogólny stan zdrowia pozwalający na leczenie (skala ECOG 0-1)
- •Mierzalny guz widoczny na zdjęciach (CT, PET/CT lub MRI)
- •Gotowość do pobrania próbki guza lub posiadanie archiwizowanej próbki
- •Oczekiwana długość życia co najmniej 3 miesiące
- •Wcześniejsze leczenie chemioterapią na bazie platyny (w większości grup)
✗ Disqualifies
- •Inny nowotwór (ostatnie 2 lata) wymagający aktywnego leczenia, z wyjątkiem czerniaków skóry lub raka szyjki macicy
- •Brak podpisanej zgody na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (38)
Zai Lab Site 2005
Duarte, United States
Zai Lab Site 2030
New Haven, United States
Zai Lab Site 2026
Sarasota, United States
Zai Lab Site 2013
Detroit, United States
Zai Lab Site 2001
Hackensack, United States
Zai Lab Site 2002
Buffalo, United States
Zai Lab Site 2018
Durham, United States
Zai Lab Site 2024
Cleveland, United States
Zai Lab Site 2029
Pittsburgh, United States
Zai Lab Site 2012
Charleston, United States
Zai Lab Site 2006
Fairfax, United States
Zai Lab Site 1004
Hefei, China
Zai Lab Site 1005
Beijing, China
Zai Lab Site 1012
Xiamen, China
Zai Lab Site 1001
Guangzhou, China
Zai Lab Site 1009
Harbin, China
Zai Lab Site 1006
Zhengzhou, China
Zai Lab 1002
Wuhan, China
Zai Lab Site 1014
Changsha, China
Zai Lab Site 1016
Nanjing, China
Zai Lab Site 1003
Nanchang, China
Zai Lab Site 1008
Ch’ang-ch’un, China
Zai Lab Site 1017
Shenyang, China
Zai Lab Site 1015
Xi'an, China
Zai Lab Site 1011
Jinan, China
Zai Lab Site 1010
Shanghai, China
Zai Lab Site 1013
Chengdu, China
Zai Lab Site 8002
Barcelona, Spain
Zai Lab Site 8003
Madrid, Spain
Zai Lab Site 8006
Madrid, Spain
Zai Lab Site 8005
Seville, Spain
Zai Lab Site 8004
Valencia, Spain
Zai Lab Site 8001
Valencia, Spain
Zai Lab Site 8007
Barcelona, Spain
Zai Lab Site 8009
Madrid, Spain
Zai Lab Site 8008
Málaga, Spain
Zai Lab Site 8010
Pozuelo de Alarcón, Spain
Zai Lab Site 8011
Seville, Spain
Trial contact
Mona Qureshi
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/24/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.